Guardant Health Investor Presentation slide image

Guardant Health Investor Presentation

Partnership with AstraZeneca to develop multiple plasma- based companion diagnostic tests TAGRISSOⓇ osimertinib GUARDANT 360 SIMFINZIⓇ durvalumab Injection for Intravenous Use 50 mg/mL GUARDANT OMNI TM 16 GUARDANT™
View entire presentation